Annual CFO
-$151.03 M
-$131.59 M-677.24%
December 31, 2024
Summary
- As of March 13, 2025, WVE annual cash flow from operations is -$151.03 million, with the most recent change of -$131.59 million (-677.24%) on December 31, 2024.
- During the last 3 years, WVE annual CFO has fallen by -$62.03 million (-69.71%).
- WVE annual CFO is now -4153.06% below its all-time high of -$3.55 million, reached on December 31, 2013.
Performance
WVE Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$43.65 M
+$2.83 M+6.09%
December 31, 2024
Summary
- As of March 13, 2025, WVE quarterly cash flow from operations is -$43.65 million, with the most recent change of +$2.83 million (+6.09%) on December 31, 2024.
- Over the past year, WVE quarterly CFO has dropped by -$10.41 million (-31.32%).
- WVE quarterly CFO is now -151.04% below its all-time high of $85.52 million, reached on March 31, 2023.
Performance
WVE Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$151.03 M
-$10.41 M-7.40%
December 31, 2024
Summary
- As of March 13, 2025, WVE TTM cash flow from operations is -$151.03 million, with the most recent change of -$10.41 million (-7.40%) on December 31, 2024.
- Over the past year, WVE TTM CFO has dropped by -$131.59 million (-677.24%).
- WVE TTM CFO is now -9228.35% below its all-time high of -$1.62 million, reached on March 31, 2015.
Performance
WVE TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
WVE Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -677.2% | -31.3% | -677.2% |
| 3 y3 years | -69.7% | -31.3% | -677.2% |
| 5 y5 years | +19.8% | -31.3% | -677.2% |
WVE Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -677.2% | at low | -151.0% | +6.1% | -6229.7% | at low |
| 5 y | 5-year | -677.2% | +19.8% | -151.0% | +28.7% | -6229.7% | +19.8% |
| alltime | all time | -4153.1% | +19.8% | -151.0% | +28.7% | -9228.4% | +19.8% |
Wave Life Sciences Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$151.03 M(+677.2%) | -$43.65 M(-6.1%) | -$151.03 M(+7.4%) |
| Sep 2024 | - | -$46.48 M(+69.2%) | -$140.62 M(+9.3%) |
| Jun 2024 | - | -$27.47 M(-17.8%) | -$128.60 M(-7.1%) |
| Mar 2024 | - | -$33.43 M(+0.6%) | -$138.38 M(+612.2%) |
| Dec 2023 | -$19.43 M(-84.8%) | -$33.24 M(-3.5%) | -$19.43 M(-1.0%) |
| Sep 2023 | - | -$34.46 M(-7.5%) | -$19.63 M(+81.4%) |
| Jun 2023 | - | -$37.26 M(-143.6%) | -$10.82 M(+353.5%) |
| Mar 2023 | - | $85.52 M(-355.7%) | -$2.39 M(-98.1%) |
| Dec 2022 | -$127.78 M(+43.6%) | -$33.44 M(+30.4%) | -$127.78 M(+26.0%) |
| Sep 2022 | - | -$25.65 M(-11.0%) | -$101.37 M(-2.4%) |
| Jun 2022 | - | -$28.82 M(-27.7%) | -$103.91 M(+23.0%) |
| Mar 2022 | - | -$39.87 M(+466.9%) | -$84.49 M(-5.1%) |
| Dec 2021 | -$88.99 M(-23.3%) | -$7.03 M(-75.0%) | -$88.99 M(-21.5%) |
| Sep 2021 | - | -$28.18 M(+199.8%) | -$113.38 M(+7.6%) |
| Jun 2021 | - | -$9.40 M(-78.8%) | -$105.36 M(-21.4%) |
| Mar 2021 | - | -$44.38 M(+41.3%) | -$134.11 M(+15.6%) |
| Dec 2020 | -$115.98 M(-38.4%) | -$31.41 M(+55.7%) | -$115.98 M(-20.5%) |
| Sep 2020 | - | -$20.17 M(-47.1%) | -$145.81 M(-13.9%) |
| Jun 2020 | - | -$38.15 M(+45.3%) | -$169.32 M(+3.2%) |
| Mar 2020 | - | -$26.25 M(-57.1%) | -$164.10 M(-12.8%) |
| Dec 2019 | -$188.23 M | -$61.24 M(+40.2%) | -$188.23 M(+17.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | -$43.68 M(+32.7%) | -$159.81 M(+10.1%) |
| Jun 2019 | - | -$32.93 M(-34.6%) | -$145.14 M(+255.6%) |
| Mar 2019 | - | -$50.38 M(+53.5%) | -$40.82 M(+78.5%) |
| Dec 2018 | -$22.86 M(-72.7%) | -$32.82 M(+13.1%) | -$22.86 M(+78.7%) |
| Sep 2018 | - | -$29.01 M(-140.6%) | -$12.80 M(+77.8%) |
| Jun 2018 | - | $71.39 M(-320.2%) | -$7.20 M(-92.7%) |
| Mar 2018 | - | -$32.43 M(+42.5%) | -$98.68 M(+17.9%) |
| Dec 2017 | -$83.67 M(+162.1%) | -$22.75 M(-2.8%) | -$83.67 M(+12.7%) |
| Sep 2017 | - | -$23.41 M(+16.5%) | -$74.26 M(+18.5%) |
| Jun 2017 | - | -$20.09 M(+15.3%) | -$62.69 M(+48.5%) |
| Mar 2017 | - | -$17.42 M(+30.5%) | -$42.21 M(+32.2%) |
| Dec 2016 | -$31.93 M(+154.8%) | -$13.35 M(+12.8%) | -$31.93 M(+26.5%) |
| Sep 2016 | - | -$11.83 M(-3133.8%) | -$25.25 M(+55.2%) |
| Jun 2016 | - | $390.00 K(-105.5%) | -$16.26 M(-9.9%) |
| Mar 2016 | - | -$7.14 M(+7.0%) | -$18.04 M(+44.0%) |
| Dec 2015 | -$12.53 M(+183.0%) | -$6.67 M(+134.1%) | -$12.53 M(+113.8%) |
| Sep 2015 | - | -$2.85 M(+104.6%) | -$5.86 M(+94.6%) |
| Jun 2015 | - | -$1.39 M(-14.0%) | -$3.01 M(+86.0%) |
| Mar 2015 | - | -$1.62 M | -$1.62 M |
| Dec 2014 | -$4.43 M(+24.6%) | - | - |
| Dec 2013 | -$3.55 M | - | - |
FAQ
- What is Wave Life Sciences annual cash flow from operations?
- What is the all time high annual CFO for Wave Life Sciences?
- What is Wave Life Sciences annual CFO year-on-year change?
- What is Wave Life Sciences quarterly cash flow from operations?
- What is the all time high quarterly CFO for Wave Life Sciences?
- What is Wave Life Sciences quarterly CFO year-on-year change?
- What is Wave Life Sciences TTM cash flow from operations?
- What is the all time high TTM CFO for Wave Life Sciences?
- What is Wave Life Sciences TTM CFO year-on-year change?
What is Wave Life Sciences annual cash flow from operations?
The current annual CFO of WVE is -$151.03 M
What is the all time high annual CFO for Wave Life Sciences?
Wave Life Sciences all-time high annual cash flow from operations is -$3.55 M
What is Wave Life Sciences annual CFO year-on-year change?
Over the past year, WVE annual cash flow from operations has changed by -$131.59 M (-677.24%)
What is Wave Life Sciences quarterly cash flow from operations?
The current quarterly CFO of WVE is -$43.65 M
What is the all time high quarterly CFO for Wave Life Sciences?
Wave Life Sciences all-time high quarterly cash flow from operations is $85.52 M
What is Wave Life Sciences quarterly CFO year-on-year change?
Over the past year, WVE quarterly cash flow from operations has changed by -$10.41 M (-31.32%)
What is Wave Life Sciences TTM cash flow from operations?
The current TTM CFO of WVE is -$151.03 M
What is the all time high TTM CFO for Wave Life Sciences?
Wave Life Sciences all-time high TTM cash flow from operations is -$1.62 M
What is Wave Life Sciences TTM CFO year-on-year change?
Over the past year, WVE TTM cash flow from operations has changed by -$131.59 M (-677.24%)